- Home
- AXS vs LNTH Comparison
AXS vs LNTH Comparison
Compare AXS & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AXS | LNTH |
|---|---|---|
| Founded | 2001 | 1956 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.3B | 4.4B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | AXS | LNTH |
|---|---|---|
| Price | $109.13 | $66.78 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 6 |
| Target Price | ★ $117.00 | $78.00 |
| AVG Volume (30 Days) | 615.0K | ★ 1.2M |
| Earning Date | 01-28-2026 | 11-06-2025 |
| Dividend Yield | ★ 1.62% | N/A |
| EPS Growth | ★ 68.27 | N/A |
| EPS | ★ 12.10 | 2.39 |
| Revenue | ★ $6,301,015,000.00 | $1,525,933,000.00 |
| Revenue This Year | $6.62 | $0.01 |
| Revenue Next Year | $8.64 | $0.52 |
| P/E Ratio | ★ $9.00 | $27.87 |
| Revenue Growth | ★ 5.59 | 1.95 |
| 52 Week Low | $83.90 | $47.25 |
| 52 Week High | $110.34 | $111.29 |
Technical Indicators
Market Signals| Indicator | AXS | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 74.32 | 65.46 |
| Support Level | $105.67 | $64.13 |
| Resistance Level | $108.12 | $68.84 |
| Average True Range (ATR) | 1.86 | 2.08 |
| MACD | 0.54 | 0.19 |
| Stochastic Oscillator | 89.62 | 75.19 |
Price Performance
Historical ComparisonAbout AXS Axis Capital Holdings Limited
Axis Capital Holdings Ltd is a specialty underwriter and provider of insurance and reinsurance solutions with operations in Bermuda, the United States ("U.S."), Europe, Singapore, and Canada. The company manages its portfolio holistically, aiming to construct an optimum consolidated portfolio of funded and unfunded risks. The company's segment consists of AXIS Insurance and AXIS Reinsurance. The company generates the majority of its revenue from the Insurance segment. Geographically, the company generates the majority of its revenue from the United States.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.